Global Extent of Chloroquine-Resistant Plasmodium Vivax – Authors' Reply

The Lancet Infectious Diseases- United Kingdom

doi 10.1016/s1473-3099(15)00018-3

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Improving Plasmodium Vivax Malaria Treatment: A Little More Chloroquine

The Lancet Infectious Diseases
Infectious Diseases
2018English

Comparison of Artesunate and Chloroquine Activities Against Plasmodium Vivax Gametocytes

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

In Vivo and in Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium Vivax

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Plasmodium Vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Polymorphisms in Chloroquine Resistance-Associated Genes in Plasmodium Vivax in Ethiopia

Malaria Journal
ParasitologyInfectious Diseases
2015English

Chloroquine-Resistant Plasmodium Malariae in South Sumatra, Indonesia

The Lancet
Medicine
2002English

The Global Public Health Significance of Plasmodium Vivax

Advances in Parasitology
MedicineParasitology
2012English

Therapeutic Responses of Plasmodium Vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Plasmodium Vivax Resistance to Chloroquine (R2) and Mefloquine (R3) in Brazilian Amazon Region

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy